// App-Quantinova.ai

888 : Improving compliance to Parkinsonism’s pharmacotherapy amongst patients attending a Movement Disorders Clinic (MDC)

Researchers

Presenter

  • M. Alsahab

Principal Investigators

  • S. Pradhan

  • A. Chatterjee

Medical Centers

  • N/A

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Central Nervous System (CNS)

Disease

  • Movement disorders

  • Parkinson's disease

Biomarkers

  • C-C Motif Chemokine Ligand 22

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A